Folliculitis Market Research Report - Forecast till 2030

Folliculitis Market Share, Growth And Trends Analysis By Type (Superficial Folliculitis, Deep Folliculitis, And Others), Treatment (Medication, Warm Compress, Medicated Shampoo, And Others), End User- Forecast Till 2030

ID: MRFR/Pharma/2535-HCR | December 2022 | Region: Global | 76 Pages         

Folliculitis Market Speak to Analyst Request a Free Sample

Folliculitis Market Overview:


The Folliculitis Market is projected to reach USD 926.7 Million by 2030 at 6.2% CAGR during the forecast period 2022-2030.


Folliculitis is very common health problems across the globe. About 3 million cases found per year in the US alone. Folliculitis can be noninfectious or infectious. Although, most of the cases of folliculitis are infectious. Increasing knowledge of folliculitis, rapid adoption of products, and increasing healthcare expenditure are driving this market.


Study objectives of folliculitis market:



  • To provide detailed analysis of the folliculitis market structure with historical and forecast revenue for the next six years of the various segments and sub-segments.

  • To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of folliculitis market

  • To provide analysis of the market with respect to various countries in the four main geographies– the Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide detailed analysis of the market segmented by type, treatment, end user, and its sub-segments.

  • To provide a detailed analysis of folliculitis market mainly based on Value Chain analysis, Porter’s Five Forces, Price analysis, and Supply Chain analysis etc.

  • To provide a detailed country level analysis of the market with respect to the current market size and future prospects.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the folliculitis market.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the folliculitis market.


FIGURE 1                   GLOBAL FOLLICULITIS MARKET SHARE BY END USER, 2016 (%) FOLLICULITIS MARKET SHARE BY END USER, 2016


Sources: American Academy of Ophthalmology, American Academy of Allergy, Asthma & Immunology, American College of Allergy, Asthma & Immunology, National Center for Biotechnology Information, Directorate of Industries, Annual report, White paper, Company Presentation


Intended Audience:



  • Folliculitis medicines manufacturers

  • Folliculitis medicine and treatment providers

  • Hospitals and clinics

  • Medical Research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology: Research Methodology folliculitis market


 Sources: American Academy of Ophthalmology, American Academy of Allergy, Asthma & Immunology, American College of Allergy, Asthma & Immunology, National Center for Biotechnology Information, Directorate of Industries, Annual report, White paper, Company Presentation


 


Segments:     


Folliculitis market has been segmented on the basis of type which comprise superficial folliculitis, deep folliculitis, and others. Superficial folliculitis is sub-segmented into bacterial folliculitis, hot tub folliculitis (pseudomonas folliculitis), barber's itch (pseudofolliculitis barbae), pityrosporum folliculitis. Deep folliculitis is sub-segmented into sycosis barbae, gram-negative folliculitis, boils (furuncles) and carbuncles, eosinophilic folliculitis.


On the basis of treatments, the market has been segmented into medication, warm compress, medicated shampoo, and others. Medication is sub-segmented into antibiotics, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), antifungals, antivirals, and others.


On the basis of end user, it is segmented into hospitals and clinics, medical research centers, academic institutes, and others.


Regional analysis of global folliculitis market:                


Considering the global scenario of the market, the Americas is holding largest market share. Some major factors are driving the growth in America such as large amount of money invested in R&D, and clinical trials. European market is second largest and countries like Germany and UK are holding largest market share. Increasing healthcare spending is major factor for Asia Pacific folliculitis market. While due to lack of knowledge of the disease and limited access to the healthcare facilities, Middle East and Africa is growing slower than the global average.


Key players for global folliculitis market:                                                     


Some of the key players in this market are: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), CELGENE CORPORATION (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), and others. The report for Global Folliculitis Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions



Report Scope:

Report Attribute/Metric Details
  Market Size   2030: USD 926.7 Million
  CAGR   6.2% (2022-2030)
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Treatment, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), CELGENE CORPORATION (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing knowledge of folliculitis
  • Rapid adoption of products
  • Increasing healthcare expenditure


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The folliculitis market CAGR would be 6.2% during the forecast period.

    The folliculitis market valuation would be USD 926.7 Million by 2030.

    North America would dominate the folliculitis market.

    The UK and Germany would dominate the folliculitis market.

    The folliculitis market players are Allergan (Republic of Ireland), AbbVie Inc. (US), CELGENE CORPORATION (US), AstraZeneca (UK), Merck & Co., Inc. (US), Pfizer Inc.(US), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline plc. (UK), and others.